TL;DR: VU0626871-1 (CAS 1024485-27-5) is a chemical compound with molecular formula C24H22N6O3 and molecular weight 442.17532 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
3-[[4-(4-pyrimidin-2-ylpiperazine-1-carbonyl)phenyl]methyl]-1H-quinazoline-2,4-dione
Also Known As: VU0626871-1, F3407-3747, 3-[[4-(4-pyrimidin-2-ylpiperazine-1-carbonyl)phenyl]methyl]-1H-quinazoline-2,4-dione, 3-(4-(4-(pyrimidin-2-yl)piperazine-1-carbonyl)benzyl)quinazoline-2,4(1H,3H)-dione, 3-({4-[4-(pyrimidin-2-yl)piperazine-1-carbonyl]phenyl}methyl)-1,2,3,4-tetrahydroquinazoline-2,4-dione
| Molecular Formula | C24H22N6O3 |
| Molecular Weight | 442.17532 g/mol |
| XLogP | 1.8 |
| Topological Polar Surface Area (TPSA) | 98.7 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Exact Mass | 442.17532 Da |
| Heavy Atoms | 33 |
| Complexity | 726.0 |
| SMILES | C1CN(CCN1C2=NC=CC=N2)C(=O)C3=CC=C(C=C3)CN4C(=O)C5=CC=CC=C5NC4=O |
| InChIKey | VSWPENXFIPAZRN-UHFFFAOYSA-N |
The XLogP value of 1.8 suggests moderate lipophilicity, balancing water solubility and membrane permeability for VU0626871-1. The TPSA of 98.7 Ų falls within the moderate polarity range, balancing permeability and solubility for VU0626871-1. Following Lipinski's Rule of Five, VU0626871-1 has 1 hydrogen bond donor(s) and 6 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
The CAS number of VU0626871-1 is 1024485-27-5.
The molecular formula of VU0626871-1 is C24H22N6O3.
The molecular weight of VU0626871-1 is 442.17532 g/mol.
You can request a quote for VU0626871-1 directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for VU0626871-1 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 1024485-27-5. Our professional technical team will respond with pricing and lead time.